What's breaking now, across thousands of outlets.
Delix Therapeutics has raised $100 million in a Series C to catch up to a budding crop of psychedelics and neuroplastogen drugmakers, cashing in on a new wave of medicines for psychiatric and mental health ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Chronic kidney disease (CKD) is common in cats but often goes undiagnosed until it's at a late stage. Thanks to a recent study published in the Journal of Proteome Research, researchers have new leads…
Precision oncology and digitally enabled cancer care are transforming what it means to live with cancer. The number of people in Europe alive more than five years after a cancer diagnosis grew 41…
Kenya has asked the World Health Organization (WHO) to intervene over travel bans and visa restrictions imposed by some countries following the Bundibugyo Ebola outbreak, arguing that blanket…
Pakistani actress Meera’s younger sister, Shaista Abbas, has died in London after battling cancer. Meera confirmed her sister’s death while … Read More The post Meera’s Sister Dies in London After…
Budi Sadikin, Indonesia’s Minister of Health and the country’s nominee for WHO Director General, has in fact spent most of his career in finance – as a top executive at Indonesia’s largest bank, PT…
For $550 million up front, Argenx will take control of Unnatural Products’ “macrocyclic peptide” technology and direct it to develop oral, durable medicines for serious immune-mediated diseases.
